A study on prevalence of obesity and menstrual disturbances in women with polycystic ovary syndrome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262092Keywords:
Polycystic ovary syndrome, Obesity, Menstrual cycle disturbancesAbstract
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age and is often linked with obesity and menstrual irregularities.
Methods: A community based cross-sectional study was conducted among 300 women with PCOS using a structured questionnaire to collect demographic data, treatment status, weight factors and menstrual characteristics. BMI categorized participants as normal weight, overweight or obese and menstrual patterns such as irregular cycles, painful periods and heavy bleeding were recorded.
Results: The findings showed a high prevalence of overweight and obesity, with many participants experiencing menstrual disturbances.
Conclusions: A strong association was observed between higher BMI and increased menstrual irregularities, highlighting the importance of early diagnosis, lifestyle modification and weight management in improving reproductive health outcomes in women with PCOS.
References
Shukla A, Rasquin LI, Anastasopoulou C. Polycystic ovarian syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2026.
Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26(7):883-96.
Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618-37.
Ganie MA, Chowdhury S, Malhotra N, Sahay R, Bhattacharya PK, Agrawal S, et al. Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women. JAMA Netw Open. 2024;7(10):e2440583.
Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V. Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus. 2022;14(12):e32351.
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24(4):223-7.
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome. Hum Reprod. 2012;27(1):14-24.
Strelec M, Solter M, Buković D, Kopjar M. Clinical, hormonal and metabolic characteristics of polycystic ovary syndrome among obese and nonobese women in the Croatian population. Coll Antropol. 2013;37(2):465-70.
Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathophysiology and management. Endocr Rev. 2019;40(3):1046-83.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(12):4565-73.
Chen X, Li L, Chen Y, Wang Y, Zhang Y, Liu H, et al. Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2024;103(8):1606-14.
Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JSE, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487-525.
Niranjani S, Prema K, Sahayarani G, Dinesh M, Carline K. Prevalence of polycystic ovarian syndrome among young college girls: a cross-sectional study. Cureus. 2025;17(9):e92623.
Moran LJ, Ko H, Misso ML, Marsh K, Noakes M, Talbot M, et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. Hum Reprod Update. 2013;19(5):432.
Downloads
Published
How to Cite
Issue
Section
